Rigel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.About RIGL
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.
CEORaul R. Rodriguez
CEORaul R. Rodriguez
Employees164
Employees164
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1996
Founded1996
Employees164
Employees164
RIGL Key Statistics
Market cap740.03M
Market cap740.03M
Price-Earnings ratio7.22
Price-Earnings ratio7.22
Dividend yield—
Dividend yield—
Average volume640.85K
Average volume640.85K
High today$45.75
High today$45.75
Low today$40.75
Low today$40.75
Open price$44.92
Open price$44.92
Volume688.43K
Volume688.43K
52 Week high$52.24
52 Week high$52.24
52 Week low$15.50
52 Week low$15.50
Stock Snapshot
The current Rigel Pharmaceuticals(RIGL) stock price is $40.88, with a market capitalization of 740.03M. The stock trades at a price-to-earnings (P/E) ratio of 7.22.
During the trading session on 2026-01-09, Rigel Pharmaceuticals(RIGL) shares reached a daily high of $45.75 and a low of $40.75. At a current price of $40.88, the stock is +0.3% higher than the low and still -10.6% under the high.
Trading activity shows a volume of 688.43K, compared to an average daily volume of 640.85K.
The stock's 52-week range extends from a low of $15.50 to a high of $52.24.
The stock's 52-week range extends from a low of $15.50 to a high of $52.24.
People also own
Based on the portfolios of people who own RIGL. This list is generated using Robinhood data, and it’s not a recommendation.